A positive inotropic effect of ATP in the human cardiac atrium

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 294, Issue 4, 2008, Pages

  Gergs, Ulrich ^a   Boknik, Peter ^a   Schmitz, Wilhelm ^a   Simm, Andreas ^b   Silber, Rolf Edgar ^b   Neumann, Joachim ^a,b  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

Adenosine 5 triphosphate; Human heart; Inotropy; Purinoceptor; Right atrium

Indexed keywords

1 [[6 (3 METHOXYESTRA 1,3,5(10) TRIEN 17BETA YL)AMINO]HEXYL] 1H PYRROLE 2,5 DIONE; 2 METHYLTHIOADENOSINE TRIPHOSPHATE; 8 CYCLOPENTYL 1,3 DIPROPYLXANTHINE; ADENOSINE 5' O (2 THIOTRIPHOSPHATE); ADENOSINE A1 RECEPTOR ANTAGONIST; ADENOSINE TRIPHOSPHATE; ADENYLATE CYCLASE INHIBITOR; CIBACRON BLUE F3GA; PHOSPHOLIPASE C INHIBITOR; PURINERGIC RECEPTOR BLOCKING AGENT; PYRIDOXAL PHOSPHATE 6 AZOPHENYL 2',4' DISULFONIC ACID; SQ 022563; SURAMIN; UNCLASSIFIED DRUG;

ADULT; AGED; ANIMAL TISSUE; ARTICLE; BYPASS SURGERY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; FEMALE; HEART ATRIUM; HEART CONTRACTION; HEART INJURY; HEART MUSCLE CONTRACTILITY; HUMAN; HUMAN TISSUE; INOTROPISM; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ADENOSINE TRIPHOSPHATE; ADENYLATE CYCLASE; AGED; AGED, 80 AND OVER; CARDIOTONIC AGENTS; CORONARY ARTERY BYPASS; CORONARY DISEASE; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTRIC STIMULATION; ENZYME INHIBITORS; ESTRENES; HEART ATRIA; HUMANS; MIDDLE AGED; MYOCARDIAL CONTRACTION; MYOCARDIUM; PYRIDOXAL PHOSPHATE; PYRROLIDINONES; RECEPTOR, ADENOSINE A1; RECEPTORS, PURINERGIC P2; SEVERITY OF ILLNESS INDEX; SIGNAL TRANSDUCTION; SURAMIN; THIONUCLEOTIDES; TRIAZINES; TYPE C PHOSPHOLIPASES; XANTHINES;

EID: 41849147917     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00945.2007     Document Type: Article

References (69)

1. Abbracchio MP, Burnstock G, Boeynaems JM, Barnard EA, Boyer JL, Kennedy C, Knight GE, Fumagalli M, Gachet C, Jacobson KA, Weisman GA. International Union of Pharmacology LVIII: update on the P2Y G protein-coupled nucleotide receptors: from molecular mechanisms and pathophysiology to therapy. Pharmacol Rev 58: 281-341, 2006.
2. Abraham EH, Prat AG, Gerweck L, Seneveratne T, Arceci RJ, Kramer R, Guidotti G, Cantiello HF. The multidrug resistance (mdr1) gene product functions as an ATP channel. Proc Natl Acad Sci USA 90: 312-316, 1993.
3. Banfi C, Ferrario S, De Vincenti O, Ceruti S, Fumagalli M, Mazzola A, D' Ambrosi N, Volonte C, Fratto P, Vitali E, Burnstock G, Beltrami E, Parolari A, Polvani G, Biglioli P, Tremoli E, Abbracchio MP. P2 receptors in human heart: upregulation of P2X6 in patients undergoing heart transplantation, interaction with TNFalpha and potential role in myocardial cell death. J Mol Cell Cardiol 39: 929 -939, 2005.
4. Behnke N, Müller W, Neumann J, Schmitz W, Scholz H, Stein B. Differential antagonism by 1,3-dipropylxanthine-8-cyclopentylxanthine and 9-chloro-2(2-furanyl)-5,6-dihydro-1,2,4-triazolo (1,5-c)quinazolin-5-imine of the effects of adenosine derivatives in the presence of isoprenaline on contractile response and cAMP content in cardiomyocytes. Evidence for the coexistence of A1- and A2-adenosine receptors on cardiomyocytes. J Pharmacol Exp Ther 254: 1017-1023, 1990.
5. Berne RM. Cardiac nucleotides in hypoxia: possible role in regulation of coronary blood flow. Am J Physiol 204: 317-322, 1963.
6. Bo X, Zhang Y, Nassar M, Burnstock G, Schoepfer R. A P2X purinoceptor cDNA conferring a novel pharmacological profile. FEBS Lett 375: 129-133, 1995.
7. Bodas E, Aleu J, Pujol G, Martin-Satué M, Marsal J, Solsona C. ATP crossing the cell plasma membrane generates an ionic current in xenopus oocytes. J Biol Chem 275: 20268-20273, 2000.
8. Böhm M, Brückner R, Neumann J, Schmitz W, Scholz H, Starbatty J. Role of guanine nucleotide-binding protein in the regulation by adenosine of cardiac potassium conductance and force of contraction. Evaluation with pertussis toxin. Naunyn-Schmiedeberg's Arch Pharmacol 332: 403-405, 1986.
9. Böhm M, Pieske B, Ungerer M, Erdmann E. Characterization of A1 adenosine receptors in atrial and ventricular myocardium from diseased human hearts. Circ Res 65: 1201-1211, 1989.
10. Borst MM, Schrader J. Adenine nucleotide release from isolated perfused guinea pig hearts and extracellular formation of adenosine. Circ Res 68: 797-806, 1991.
11. Bowditch J, Brown AK, Dow JW. Accumulation and salvage of adenosine and inosine by isolated mature cardiac myocytes. Biochim Biophys Acta 844: 119-128, 1985.
12. Bowler JW, Bailey RJ, North RA, Surprenant A. P2X4, P2Y1 and P2Y2 receptors on rat alveolar macrophages. Br J Pharmacol 140: 567-575, 2003.
13. Burnstock G, Campbell G, Satchell D, Smythe A. Evidence that adenosine triphosphate or a related nucleotide is the transmitter substance released by non-adrenergic inhibitory nerves in the gut. Br J Pharmacol 40: 668-688, 1970.
14. Burnstock g. Purinergic nerves. Pharmacol Rev 24: 509-581, 1972.
15. Burnstock G, Meghji P. Distribution of P1- and P2-purinoceptors in the guinea-pig and frog heart. Br J Pharmacol 73: 879-885, 1981.
16. Collo G, North RA, Kawashima E, Merlo-Pich E, Neidhart S, Surprenant A, Buell G. Cloning OF P2X5 and P2X6 receptors and the distribution and properties of an extended family of ATP-gated ion channels. J Neurosci 16: 2495-2507, 1996.
17. Cotrina ML, Lin JH, Alves-Rodrigues A, Liu S, Li J, Azmi-Ghadimi H, Kang J, Naus CC, Nedergaard M. Connexins regulate calcium signaling by controlling ATP release. Proc Natl Acad Sci USA 95: 15735-15740, 1998.
18. Day HJ, Holmsen H. Concepts of the blood platelet release reaction. Ser Haematol 4: 3-27, 1971.
19. Drury AN, Szent-Gyorgyi A. The physiological activity of adenine compounds with especial reference to their action upon the mammalian heart. J Physiol 68: 213-237, 1929.
20. Dutta AK, Sabirov RZ, Uramoto H, Okada Y. Role of ATP-conductive anion channel in ATP release from neonatal rat cardiomyocytes in ischaemic or hypoxic conditions. J Physiol 559: 799-812, 2004.
21. Fabiato A, Fabiato F. Effects of pH on the myofilaments and the sarcoplasmic reticulum of skinned cells from cardiace and skeletal muscles. J Physiol 276: 233-255, 1978.
22. Fischer Y, Becker C, Loken C. Purinergic inhibition of glucose transport in cardiomyocytes. J Biol Chem 274: 755-761, 1999.
23. Fountain SJ, North RA. A C-terminal lysine that controls human P2X4 receptor desensitization. J Biol Chem 281: 15044-15049, 2006.
24. Fredholm BB, Abbracchio MP, Burnstock G, Daly JW, Harden TK, Jacobson KA, Leff P, Williams M. Nomenclature and classification of purinoceptors. Pharmacol Rev 46: 143-156, 1994.
25. Froldi G, Pandolfo L, Chinellato A, Ragazzi E, Caparrotta L, Fassina G. Dual effect of ATP and UTP on rat atria: which types of receptors are involved? Naunyn Schmiedeberg's Arch Pharmacol 349: 381-386, 1994.
26. Gergs U, Boknik P, Schmitz W, Simm A, Silber RE, Illes P, Neumann J. ATP modified contraction in the human heart (Abstract). Naunyn-Schmiedeberg's Arch Pharmacol 375, Suppl 1: 63, 2007.
27. Gupta RC, Neumann J, Durant P, Watanabe AM. A1-adenosine-receptor mediated inhibition of isoproterenol-stimulated protein phosphorylation in ventricular myocytes. Evidence against a cyclic AMP-dependent effect. Circ Res 72: 65-74, 1993.
28. Gupta RC, Neumann J, Watanabe AM. Comparison of adenosine and muscarinic receptor mediated effects on phosphatase inhibitor-1 activity in the heart. J Pharmacol Exp Ther 266: 16-22, 1993.
29. Hirano Y, Abe S, Sawanobori T, Hiraoka M. Arachidonic acid induced increase in intracellular free calcium in guinea-pig hepatocytes. Jpn J Physiol 41: 327-332, 1991.
30. Hisadome K, Koyama T, Kimura C, Droogmans G, Ito Y, Oike M. Volume-regulated anion channels serve as an auto/paracrine nucleotide release pathway in aortic endothelial cells. J Gen Physiol 119: 511-520, 2002.
31. Hu B, Mei QB, Yao XJ, Smith E, Barry WH, Liang BT. A novel contractile phenotype with cardiac transgenic expression of the human P2X4 receptor. FASEB J 15: 2739-2741, 2001.
32. Jones CA, Chessell IP, Simon J, Barnard EA, Miller KJ, Michel AD, Humphrey PP. Functional characterization of the P2X(4) receptor orthologues. Br J Pharmacol 129: 388-394, 2000.
33. Jorgensen S. Breakdown of adenine and hypoxanthine nucleotides and nucleosides in human plasma. Acta Pharmacol Toxicol (Copenh) 12: 294-302, 1956.
34. Kennedy C, Qi AD, Herold CL, Harden TK, Nicholas RA. ATP, an agonist at the rat P2Y(4) receptor, is an antagonist at the human P2Y(4) receptor. Mol Pharmacol 57: 926-931, 2000.
35. Kennedy C. P2X receptors: targets for novel analgesics? Neuroscientist 11: 345-356, 2005.
36. Khakh BS, Burnstock G, Kennedy C, King BF, North RA, Séguéla P, Voigt M, Humphrey PP. International union of pharmacology. XXIV. Current status of the nomenclature and properties of P2X receptors and their subunits. Pharmacol Rev 53: 107-118, 2001.
37. Kichenin K, Decollogne S, Angignard J, Seman M. Cardiovascular and pulmonary response to oral administration of ATP in rabbits. J Appl Physiol 88: 1962-1968, 2000.
38. Kirchhefer U, Baba HA, Kobayashi YM, Jones LR, Schmitz W, Neumann J. Altered function in atrium of transgenic mice overexpressing triadin 1. Am J Physiol Heart Circ Physiol 283: H1334-H1343, 2002.
39. Kuzmin AI, Lakomkin VL, Kapelko VI, Vassort G. Interstitial ATP level and degradation in control and postmyocardial infracted rats. Am J Physiol Cell Physiol 275: C766-C771, 1998.
40. Lambrecht G. Agonists and antagonists acting at P2X receptors: selectivity profiles and functional implications. Naunyn Schmiedebergs Arch Pharmacol 362: 340-350, 2000.
41. Legssyer A, Poggioli J, Renard D, Vassort G. ATP and other adenine compounds increase mechanical activity and inositol trisphosphate production in rat heart. J Physiol 401: 185-199, 1988.
42. Lohse MJ, Boser S, Klotz KN, Schwabe U. Affinities of barbiturates for the GABA-receptor complex and A1 adenosine receptors: a possible explanation of their excitatory effects. Naunyn Schmiedebergs Arch Pharmacol 336: 211-217, 1987.
43. Mantelli L, Amerini S, Filippi S, Ledda F. Blockade of adenosine receptors unmasks a stimulatory effect of ATP on cardiac contractility. Br J Pharmacol 109: 1268-1271, 1993.
44. Mei Q, Liang BT. P2 purinergic receptor activation enhances cardiac contractility in isolated rat and mouse hearts. Am J Physiol Heart Circ Physiol 281: H334-H341, 2001.
45. Monahan TS, Sawmiller DR, Fenton RA, Dobson JG Jr. Adenosine A(2a)-receptor activation increases contractility in isolated perfused hearts. Am J Physiol Heart Circ Physiol 279: H1472-H1481, 2000.
46. Munkonda MN, Kauffenstein G, Kukulski F, Levesque SA, Legendre C, Pelletier J, Lavoie EG, Lecka J, Sevigny J. Inhibition of human and mouse plasma membrane bound NTPDases by P2 receptor antagonists. Biochem Pharmacol 74: 1524-1534, 2007.
47. Needleman P, Minkes MS, Douglas JR Jr. Stimulation of prostaglandin biosynthesis by adenine nucleotides. Profile of prostaglandin release by perfused organs. Circ Res 34: 455-460, 1974.
48. Neumann J, Schmitz W, Scholz H, Stein B. Effects of adenosine analogues on contractile response and cAMP content in guinea-pig isolated ventricular myocytes. Naunyn-Schmiedeberg's Arch Pharmacol 340: 689-695, 1989.
49. 2+ responses in bovine aortic endothelial cells. Am J Physiol Heart Circ Physiol 279: H630-H638, 2000.
50. Podrasky Ernest David Xu, Bruce Liang T. A novel phospholipase C-and cAMP-independent positive inotropic mechanism via a P2 purinoceptor. Am J Physiol Heart Circ Physiol 273: H2380-H2387, 1997.
51. Puceat M, Clement-Chomienne O, Terzic A, Vassort G. Alpha 1-adrenoceptor and purinoceptor agonists modulate Na-H antiport in single cardiac cells. Am J Physiol Heart Circ Physiol 264: H310-H319, 1993.
52. Ralevic V, Burnstock G. Receptors for purines and pyrimidines. Pharmacol Rev 50: 413-492, 1998.
53. Saito D, Ueeda M, Abe Y, Tani H, Nakatsu T, Yoshida H, Haraoka S, Nagashima H. Treatment of paroxysmal supraventricular tachycardia with intravenous injection of adenosine triphosphate. Br Heart J 55: 291-294, 1986.
54. Scamps F, Legssyer A, Mayoux E, Vassort G. The mechanism of positive inotropy induced by adenosine triphosphate in rat heart. Circ Res 67: 1007-1016, 1990.
55. Shen JB, Pappano AJ, Liang BT. Extracellular ATP-stimulated current inwild-type and P2X4 receptor transgenic mouse ventricular myocytes: implications for a cardiac physiologic role of P2X4 receptors. FASEB J 20: 277-284, 2006.
56. Sugita M, Yue Y, Foskett JK. CFTR Cl- channel and CFTR-associated ATP channel: distinct pores regulated by common gates. EMBO J 17: 898-908, 1998.
57. Tatur S, Groulx N, Orlov SN, Grygorczyk R. Ca2+-dependent ATP release from A549 cells involves synergistic autocrine stimulation by coreleased uridine nucleotides. J Physiol 584: 419-435, 2007.
58. Traut TW. Physiological concentrations of purines and pyrimidines. Mol Cell Biochem 140: 1-22, 1994.
59. Uozumi H, Kudoh S, Zou Y, Harada K, Yamazaki T, Komuro I. Autocrine release of ATP mediates mechanical stress-induced cardiomyocytes hypertrophy (Abstract). Circulation 98: I624, 1998.
60. Vahlensieck U, Boknik P, Knapp J, Linck B, Müller FU, Neumann J, Schmitz W, Herzig S, Gross I, Schlüter H, Zidek W, Deng MC, Scheld HH. Negative chronotropic and inotropic effects exerted by diadenosine hexaphosphate (AP6A) via A1-adenosine receptors. Br J Pharmacol 119: 835-844, 1996.
61. Vahlensieck U, Boknik P, Gombosova I, Huke S, Knapp J, Linck B, Lüss H, Müller FU, Neumann J, Deng MC, Scheld HH, Jankowski H, Schlüter H, Zidek W, Zimmermann N, Schmitz W. Inotropic effects of diadenosine tetraphosphate (AP4A) in human and animal cardiac preparations. J Pharmacol Exp Ther 288: 805-813, 1999.
62. Vassort G. Adenosine 5′-triphosphate: a P2-purinergic agonist in the myocardium. Physiol Rev 81: 767-806, 2001.
63. von Kügelgen I. Pharmacological profiles of cloned mammalian P2Y-receptor subtypes. Pharmacol Ther 110: 415-432, 2006.
64. Wee S, Peart JN, Headrick JP. P2 Purinoceptor-Mediated Cardioprotection in Ischemic-Reperfused Mouse Heart. J Pharmacol Exp Ther September 12, 2007;doi:10.1124/jpet.107.125815.
65. Welford LA, Cusack NJ, Hourani SM. The structure-activity relationships of ectonucleotidases and of excitatory P2-purinoceptors: evidence that dephosphorylation of ATP analogues reduces pharmacological potency. Eur J Pharmacol 141: 123-130, 1987.
66. Wihlborg AK, Balogh J, Wang L, Borna C, Dou Y, Joshi BV, Lazarowski E, Jacobson KA, Arner A, Erlinge D. Positive inotropic effects by uridine triphosphate (UTP) and uridine diphosphate (UDP) via P2Y2 and P2Y6 receptors on cardiomyocytes and release of UTP in man during myocardial infarction. Circ Res 98: 970-976, 2006.
67. 2X4 receptors in heart failure: rescue of the calsequestrin overexpression model of cardiomyopathy. Am J Physiol Heart Circ Physiol 287: H1096-H1103, 2004.
68. Zheng JS, Boluyt MO, Long X, ONeill L, Lakatta EG, Crow MT. Extracellular ATP inhibits adrenergic agonist-induced hypertrophy of neonatal cardiac myocytes. Circ Res 78: 525-535, 1996.
69. Zimmermann N, Nacke P, Neumann J, Winter J, Gams E. Inotropic effects of diadenosine monophosphate (AP1A) in isolated human cardiac preparations. J Cardiovasc Pharmacol 35: 881-886, 2000.